News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
David Steensma: Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances
Photo from David Steensma/X
Nov 12, 2023, 17:42

David Steensma: Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances

David Steensma, Chief Medical Officer of Ajax Therapeutics, posted on X/Twitter.

“Our proteomics analysis of the large CANTOS CV trial is now online Blood Advances led by Janghee Woo (now Winship Cancer Institute of Emory). Clonal hematopoiesis was associated with incident anemia and markers of inflammation which were attenuated by IL-1b inhibitor therapy.”

Source: David Steensma/X

cancer CANTOS CV David Steensma IL-1b inhibition Janghee Woo OncoDaily Oncology
Special Coverage
Blog
Apr 7, 2025, 00:43
Global Cancer Research and Control Seminar Series with Yannick Romero and Zuzanna Tittenbrun - NCI Center for Global Health
Blog
Apr 6, 2025, 17:46
Fifth Eye joins CancerX 2025 Accelerator
Blog
Apr 6, 2025, 17:36
Isabel Mestres: Kochi could officially join City Cancer Challenge
Blog
Apr 6, 2025, 17:24
Zorana Maravic speaking at the Amsterdam Biosimilar Medicines Conference - Digestive Cancers Europe
Science
Apr 6, 2025, 17:10
Christian Badr: Targeting SCD could be a promising strategy for developing more effective treatments for BCBM
Blog
Apr 6, 2025, 16:58
Giuseppe Lombardi: An important webinar with neuro-oncology experts on glioblastoma and meningioma
Blog
Apr 6, 2025, 16:46
The three modules of the SPCC-All.Can International online courses are available on-demand
Blog
Apr 6, 2025, 16:35
Wade Swenson: Zachary Schroeder’s experience with rural patients and families in his TEDx talk
Blog
Apr 6, 2025, 16:12
What does 'conquering cancer' mean to you professionally or personally? - Conquer Cancer, the ASCO Foundation
Blog
Apr 6, 2025, 16:08
Andrew M. Evens: Day 2 of the 22nd annual International Ultmann Chicago Lymphoma Symposium
Insight
Apr 6, 2025, 15:27
Ashish Kamat: Hybrid 3-Tier Bladder Cancer Grade - The Mutually Beneficial Marriage of 2 Grading Systems
Blog
Apr 6, 2025, 15:26
Lisa Lacasse: It’s been a little over a week since we celebrated the life of my dear friend, Keysha Brooks-Coley